A direct inhibitory effect of Botulinum toxin type A on antral circular muscle contractility of Guinea pig

Jung Ho Park, Eun Joo Choi, Hyojin Park, Yong Ho Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Recent studies suggest new mechanisms of Botulinum toxin (BoNT) other than inhibiting acetylcholine (ACh) release from nerve terminals. The aim of this study was to determine whether other mechanisms for BoNT exist, so that it directly inhibits smooth muscle contraction. Materials and Methods: Guinea pig antral muscle strips were studied in vitro after 2 hours of exposure to Botulinum toxin type A (BoNT/A). Contractile responses to electric field stimulation (EFS), high K+ (60 mM) and ACh (100 μM) were evaluated 24 and 48 hours after antral intramuscular injection of BoNT/A or vehicle. Results: BoNT/A inhibited muscular contraction caused by high K+ and ACh. Contractile responses to low (1 & 4 Hz) and high (8 & 20 Hz) frequency EFS of antral muscle strips 24 and 48 hours after antral intramuscular injection of BoNT/A were significantly inhibited. Conclusion: The ability of BoNT/A to directly inhibit antral muscular contractility suggests a new mechanism for the pharmacologic actions of BoNT-direct inhibition of muscular contraction.

Original languageEnglish
Pages (from-to)968-973
Number of pages6
JournalYonsei medical journal
Volume53
Issue number5
DOIs
Publication statusPublished - 2012 Jul

Fingerprint

Type A Botulinum Toxins
Guinea Pigs
Botulinum Toxins
Muscles
Muscle Contraction
Acetylcholine
Intramuscular Injections
Electric Stimulation
Pharmacologic Actions
Smooth Muscle
Antral

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{c9fac142cf5243cda0e9a0138fff07c0,
title = "A direct inhibitory effect of Botulinum toxin type A on antral circular muscle contractility of Guinea pig",
abstract = "Purpose: Recent studies suggest new mechanisms of Botulinum toxin (BoNT) other than inhibiting acetylcholine (ACh) release from nerve terminals. The aim of this study was to determine whether other mechanisms for BoNT exist, so that it directly inhibits smooth muscle contraction. Materials and Methods: Guinea pig antral muscle strips were studied in vitro after 2 hours of exposure to Botulinum toxin type A (BoNT/A). Contractile responses to electric field stimulation (EFS), high K+ (60 mM) and ACh (100 μM) were evaluated 24 and 48 hours after antral intramuscular injection of BoNT/A or vehicle. Results: BoNT/A inhibited muscular contraction caused by high K+ and ACh. Contractile responses to low (1 & 4 Hz) and high (8 & 20 Hz) frequency EFS of antral muscle strips 24 and 48 hours after antral intramuscular injection of BoNT/A were significantly inhibited. Conclusion: The ability of BoNT/A to directly inhibit antral muscular contractility suggests a new mechanism for the pharmacologic actions of BoNT-direct inhibition of muscular contraction.",
author = "Park, {Jung Ho} and Choi, {Eun Joo} and Hyojin Park and Lee, {Yong Ho}",
year = "2012",
month = "7",
doi = "10.3349/ymj.2012.53.5.968",
language = "English",
volume = "53",
pages = "968--973",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "5",

}

A direct inhibitory effect of Botulinum toxin type A on antral circular muscle contractility of Guinea pig. / Park, Jung Ho; Choi, Eun Joo; Park, Hyojin; Lee, Yong Ho.

In: Yonsei medical journal, Vol. 53, No. 5, 07.2012, p. 968-973.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A direct inhibitory effect of Botulinum toxin type A on antral circular muscle contractility of Guinea pig

AU - Park, Jung Ho

AU - Choi, Eun Joo

AU - Park, Hyojin

AU - Lee, Yong Ho

PY - 2012/7

Y1 - 2012/7

N2 - Purpose: Recent studies suggest new mechanisms of Botulinum toxin (BoNT) other than inhibiting acetylcholine (ACh) release from nerve terminals. The aim of this study was to determine whether other mechanisms for BoNT exist, so that it directly inhibits smooth muscle contraction. Materials and Methods: Guinea pig antral muscle strips were studied in vitro after 2 hours of exposure to Botulinum toxin type A (BoNT/A). Contractile responses to electric field stimulation (EFS), high K+ (60 mM) and ACh (100 μM) were evaluated 24 and 48 hours after antral intramuscular injection of BoNT/A or vehicle. Results: BoNT/A inhibited muscular contraction caused by high K+ and ACh. Contractile responses to low (1 & 4 Hz) and high (8 & 20 Hz) frequency EFS of antral muscle strips 24 and 48 hours after antral intramuscular injection of BoNT/A were significantly inhibited. Conclusion: The ability of BoNT/A to directly inhibit antral muscular contractility suggests a new mechanism for the pharmacologic actions of BoNT-direct inhibition of muscular contraction.

AB - Purpose: Recent studies suggest new mechanisms of Botulinum toxin (BoNT) other than inhibiting acetylcholine (ACh) release from nerve terminals. The aim of this study was to determine whether other mechanisms for BoNT exist, so that it directly inhibits smooth muscle contraction. Materials and Methods: Guinea pig antral muscle strips were studied in vitro after 2 hours of exposure to Botulinum toxin type A (BoNT/A). Contractile responses to electric field stimulation (EFS), high K+ (60 mM) and ACh (100 μM) were evaluated 24 and 48 hours after antral intramuscular injection of BoNT/A or vehicle. Results: BoNT/A inhibited muscular contraction caused by high K+ and ACh. Contractile responses to low (1 & 4 Hz) and high (8 & 20 Hz) frequency EFS of antral muscle strips 24 and 48 hours after antral intramuscular injection of BoNT/A were significantly inhibited. Conclusion: The ability of BoNT/A to directly inhibit antral muscular contractility suggests a new mechanism for the pharmacologic actions of BoNT-direct inhibition of muscular contraction.

UR - http://www.scopus.com/inward/record.url?scp=84864592286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864592286&partnerID=8YFLogxK

U2 - 10.3349/ymj.2012.53.5.968

DO - 10.3349/ymj.2012.53.5.968

M3 - Article

C2 - 22869480

AN - SCOPUS:84864592286

VL - 53

SP - 968

EP - 973

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 5

ER -